Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

115.46USD
1 Sep 2015
Change (% chg)

-- (--)
Prev Close
$115.46
Open
--
Day's High
--
Day's Low
--
Volume
25
Avg. Vol
4,889,814
52-wk High
$140.72
52-wk Low
$83.16

Search Stocks
Daniel (Thomas O) Options Exercised: 0
Trade Date: Thursday, 6 Feb 2014 Price: 39.01
Title: Officer Shares Held: 20,463
Type Traded: Direct Net Change in Shares This Filing: 0

Institutional Holders

% Shares Owned: 81.70%
# of Holders: 1,574
Total Shares Held: 645,889,528
3 Mo. Net Change: -8,508,299
# New Positions: 90
# Closed Positions: 86
# Increased Positions: 589
# Reduced Positions: 661
# Net Buyers: -72

Officers & Directors

Name Age Since Current Position

Robert Hugin

60 2014 Chairman of the Board, Chief Executive Officer

Mark Alles

56 2014 President, Chief Operating Officer

Thomas Daniel

61 2014 President, Research and Early Development

Peter Kellogg

59 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

54 2014 President - Hematology & Oncology

Perry Karsen

60 2013 Chief Executive Officer of Celgene Cellular Therapeutics

Scott Smith

53 2014 President - Inflammation & Immunology

Michael Casey

69 2007 Lead Independent Director

Michael Bonney

56 2015 Director

Richard Barker

66 2012 Independent Director

Carrie Cox

57 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

68 1998 Independent Director

James Loughlin

72 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks